A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy
| Autor: | Hila Fruchtman, Albert Grinshpun, Dean Nachman, Irit Merlet |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty palbociclib COVID19 Case Report Palbociclib lcsh:RC254-282 Systemic therapy Disease course CDK4/6 inhibitors 03 medical and health sciences Protracted course 0302 clinical medicine Immune system Internal medicine medicine pneumonia In patient business.industry lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease Metastatic breast cancer Pneumonia 030104 developmental biology 030220 oncology & carcinogenesis metastatic breast cancer business |
| Zdroj: | Frontiers in Oncology, Vol 10 (2020) Frontiers in Oncology |
| ISSN: | 2234-943X |
| DOI: | 10.3389/fonc.2020.01085 |
| Popis: | We describe the first case report of a patient with COVID19 infection and metastatic breast cancer, while on systemic therapy with a CDK4/6 inhibitor. The patient had unique disease course, characterized with delayed symptomatology. The case highlights novel findings and stress careful and extended follow-up during COVID19 infection in patients taking biologic therapies affecting the immune system. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|